After adding ezetimibe 10 mg/day to ongoing statin mono-therapy, an additional mean LDL cholesterol reduction of 25.1% was seen, while addition of placebo reduced the LDL cholesterol level by 3.7% (P < 0.001). Maximal effect was seen at week 2 and was maintained throughout the 8-week treatment period.